Hospitals may use certain intravenous solutions made by Baxter Healthcare Corp. beyond the labeled expiration date due to the ongoing shortage of IV solutions used in critical care, the Food and Drug Administration announced today. Health care professionals should squeeze the bags before use and not use them if leaks are found, the agency said. The products should continue to be stored as labeled, and should be replaced and properly disposed of as soon as possible if replacement product becomes available during the extension period, FDA said.
 

Related News Articles

Headline
Members of the pharmaceutical distribution supply chain, including dispensers such as hospitals and pharmacies, can apply through March 11 to participate in a…
Headline
The U.S. District Court for the Western District of Pennsylvania has entered a consent decree prohibiting Ranier’s Rx Laboratory Inc. from manufacturing or…
Headline
The Food and Drug Administration Friday warned physicians and patients who use medical devices to monitor levels of the blood thinner warfarin that certain…
Headline
The AHA today submitted to the Food and Drug Administration legislative, regulatory and best practice recommendations to address new and chronic prescription…
Headline
The Food and Drug Administration yesterday released revised draft guidance for facilities that compound human drugs as outsourcing facilities.
Headline
The AHA, American Society of Anesthesiologists, American Society of Clinical Oncology, American Society of Health-System Pharmacists, and Institute for Safe…